{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T13:38:47Z","timestamp":1794836327432,"version":"4.9.1"},"reference-count":91,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.eprac.2025.05.743","type":"journal-article","created":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T18:40:32Z","timestamp":1748112032000},"page":"965-974","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Imaging of Adrenal Masses"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6745-1410","authenticated-orcid":false,"given":"Francis T.","family":"Delaney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Blake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann T.","family":"Sweeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.eprac.2025.05.743_bib1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4158\/EP.1.2.77","article-title":"Acth-independent Cushing's syndrome: bilateral cortisol-producing adrenal adenomas","volume":"1","author":"Dinneen","year":"1995","journal-title":"Endocr Pract"},{"issue":"2","key":"10.1016\/j.eprac.2025.05.743_bib2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4158\/EP.1.2.91","article-title":"Endocrine hypertension","volume":"1","author":"Kaplan","year":"1995","journal-title":"Endocr Pract"},{"issue":"25","key":"10.1016\/j.eprac.2025.05.743_bib3","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1056\/NEJMc066006","article-title":"Clinical and genetic characteristics of patients with neurofibromatosis type 1 and pheochromocytoma","volume":"354","author":"Bausch","year":"2006","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.eprac.2025.05.743_bib4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1086\/321282","article-title":"Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma","volume":"69","author":"Astuti","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"5944","key":"10.1016\/j.eprac.2025.05.743_bib5","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1126\/science.1175689","article-title":"SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma","volume":"325","author":"Hao","year":"2009","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.eprac.2025.05.743_bib6","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJMra1806651","article-title":"Pheochromocytoma and paraganglioma","volume":"381","author":"Neumann","year":"2019","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.eprac.2025.05.743_bib7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1210\/endrev\/bnab019","article-title":"Personalized management of pheochromocytoma and paraganglioma","volume":"43","author":"N\u00f6lting","year":"2022","journal-title":"Endocr Rev"},{"issue":"3","key":"10.1016\/j.eprac.2025.05.743_bib8","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1210\/endrev\/bnae001","article-title":"Imaging of pheochromocytomas and paragangliomas","volume":"45","author":"Timmers","year":"2024","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.eprac.2025.05.743_bib9","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1038\/s41467-025-57595-y","article-title":"Multi-omic analysis of SDHB-deficient pheochromocytomas and paragangliomas identifies metastasis and treatment-related molecular profiles","volume":"16","author":"Flynn","year":"2025","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.eprac.2025.05.743_bib10","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S2213-8587(20)30218-7","article-title":"Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study","volume":"8","author":"Bancos","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"10.1016\/j.eprac.2025.05.743_bib11","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1210\/clinem\/dgae604","article-title":"Serum steroid profiling in the diagnosis of adrenocortical carcinoma: a prospective cohort study","volume":"110","author":"Yu","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.eprac.2025.05.743_bib12","first-page":"952","article-title":"Lexicon for adrenal terms at CT and MRI: a consensus of the Society of Abdominal Radiology adrenal neoplasm disease-focused panel","volume":"48","author":"Glazer","year":"2023","journal-title":"Abdom Radiol (Ny)"},{"issue":"6","key":"10.1016\/j.eprac.2025.05.743_bib13","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1056\/NEJMcp065470","article-title":"Clinical practice. The incidentally discovered adrenal mass","volume":"356","author":"Young","year":"2007","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.eprac.2025.05.743_bib14","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1093\/ejendo\/lvad066","article-title":"European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors","volume":"189","author":"Fassnacht","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"10.1016\/j.eprac.2025.05.743_bib15","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.7326\/M22-1619","article-title":"Prevalence and characteristics of adrenal tumors in an unselected screening population : a cross-sectional study","volume":"175","author":"Jing","year":"2022","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.eprac.2025.05.743_bib16","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S2213-8587(20)30314-4","article-title":"Epidemiology of adrenal tumours in Olmsted County, Minnesota, USA: a population-based cohort study","volume":"8","author":"Ebbehoj","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11S","key":"10.1016\/j.eprac.2025.05.743_bib17","doi-asserted-by":"crossref","first-page":"S251","DOI":"10.1016\/j.jacr.2021.08.010","article-title":"ACR appropriateness Criteria\u00ae adrenal mass evaluation: 2021 update","volume":"18","author":"Mody","year":"2021","journal-title":"J Am Coll Radiol"},{"issue":"6","key":"10.1016\/j.eprac.2025.05.743_bib18","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1530\/EJE-10-1147","article-title":"AME position statement on adrenal incidentaloma","volume":"164","author":"Terzolo","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.eprac.2025.05.743_bib19","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/bjs.1800800405","article-title":"Adrenal incidentaloma","volume":"80","author":"Gajraj","year":"1993","journal-title":"Br J Surg"},{"issue":"5","key":"10.1016\/j.eprac.2025.05.743_bib20","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S2213-8587(13)70211-0","article-title":"Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study","volume":"2","author":"Di Dalmazi","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"10.1016\/j.eprac.2025.05.743_bib21","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European society of Endocrinology clinical practice guideline in collaboration with the European network for the study of adrenal tumors","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.eprac.2025.05.743_bib22","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz284","article-title":"Adrenal incidentalomas are tied to increased risk of diabetes: findings from a prospective study","volume":"105","author":"Reimondo","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.eprac.2025.05.743_bib91","first-page":"102748","article-title":"French AFU Cancer Committee Guidelines - Update 2024-2026: Assessment of an adrenal incidentaloma and oncological management","volume":"34","author":"Savoie","year":"2024","journal-title":"Fr J Urol. Nov"},{"issue":"1","key":"10.1016\/j.eprac.2025.05.743_bib23","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12022-022-09704-6","article-title":"Overview of the 2022 WHO classification of paragangliomas and pheochromocytomas","volume":"33","author":"Mete","year":"2022","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.eprac.2025.05.743_bib24","article-title":"Adrenocortical carcinoma: diagnosis, prognostic classification and treatment of localized and advanced disease","volume":"37","author":"Lib\u00e9","year":"2023","journal-title":"Cancer Treat Res Commun"},{"issue":"5","key":"10.1016\/j.eprac.2025.05.743_bib25","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.2214\/AJR.07.2799","article-title":"The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy","volume":"190","author":"Song","year":"2008","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.eprac.2025.05.743_bib26","first-page":"55","article-title":"Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates","volume":"83","author":"Barzon","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"4-6","key":"10.1016\/j.eprac.2025.05.743_bib27","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000185477","article-title":"Adrenal incidentaloma: an overview of clinical and epidemiological data from the National Italian Study Group","volume":"47","author":"Angeli","year":"1997","journal-title":"Horm Res"},{"issue":"10","key":"10.1016\/j.eprac.2025.05.743_bib28","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3109\/02841851.2010.516016","article-title":"Adrenal lesion frequency: a prospective, cross-sectional CT study in a defined region, including systematic re-evaluation","volume":"51","author":"Hammarstedt","year":"2010","journal-title":"Acta Radiol"},{"issue":"10","key":"10.1016\/j.eprac.2025.05.743_bib29","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/bjs.7566","article-title":"Cohort study of patients with adrenal lesions discovered incidentally","volume":"98","author":"Muth","year":"2011","journal-title":"Br J Surg"},{"issue":"10","key":"10.1016\/j.eprac.2025.05.743_bib30","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.eprac.2024.06.015","article-title":"Clinical review: the approach to the evaluation and management of bilateral adrenal masses","volume":"30","author":"Sweeney","year":"2024","journal-title":"Endocr Pract"},{"issue":"8","key":"10.1016\/j.eprac.2025.05.743_bib31","doi-asserted-by":"crossref","first-page":"870","DOI":"10.4158\/EP15618.OR","article-title":"Clinical outcomes in adrenal incidentaloma: experience from one center","volume":"21","author":"Patrova","year":"2015","journal-title":"Endocr Pract"},{"issue":"2","key":"10.1016\/j.eprac.2025.05.743_bib32","first-page":"637","article-title":"A survey on adrenal incidentaloma in Italy. Study group on adrenal tumors of the Italian society of Endocrinology","volume":"85","author":"Mantero","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.eprac.2025.05.743_bib33","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1046\/j.1365-2265.1997.d01-1751.x","article-title":"Incidentally discovered adrenal mass (incidentaloma): investigation and management of 208 patients","volume":"46","author":"Kasperlik-Zeluska","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"10.1016\/j.eprac.2025.05.743_bib34","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1001\/jamasurg.2015.1683","article-title":"Differences between bilateral adrenal incidentalomas and unilateral lesions","volume":"150","author":"Pasternak","year":"2015","journal-title":"JAMA Surg"},{"issue":"11","key":"10.1016\/j.eprac.2025.05.743_bib35","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nrendo.2011.92","article-title":"Endocrine incidentalomas--challenges imposed by incidentally discovered lesions","volume":"7","author":"Vassiliadi","year":"2011","journal-title":"Nat Rev Endocrinol"},{"issue":"8","key":"10.1016\/j.eprac.2025.05.743_bib36","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.8898","article-title":"Comparison of pheochromocytoma-specific morbidity and mortality Among adults with bilateral pheochromocytomas undergoing total adrenalectomy vs cortical-sparing adrenalectomy","volume":"2","author":"Neumann","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.eprac.2025.05.743_bib37","first-page":"76","article-title":"Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1","volume":"75","author":"Skogseid","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.eprac.2025.05.743_bib38","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.mayocp.2023.10.002","article-title":"Adrenal hemorrhage: a comprehensive analysis of a heterogeneous entity-etiology, presentation, management, and outcomes","volume":"99","author":"Dogra","year":"2024","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"10.1016\/j.eprac.2025.05.743_bib39","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1530\/EJE-19-0506","article-title":"Clinical spectrum of primary adrenal lymphoma: results of a multicenter cohort study","volume":"183","author":"Majidi","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.eprac.2025.05.743_bib40","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.eprac.2025.05.743_bib41","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.2214\/AJR.10.4547","article-title":"Adrenal imaging","volume":"194","author":"Blake","year":"2010","journal-title":"Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.eprac.2025.05.743_bib42","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2214\/ajr.171.1.9648789","article-title":"Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature","volume":"171","author":"Boland","year":"1998","journal-title":"Am J Roentgenol"},{"issue":"3","key":"10.1016\/j.eprac.2025.05.743_bib43","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1067\/cdr.2002.125403","article-title":"State of the art in adrenal imaging","volume":"31","author":"Blake","year":"2002","journal-title":"Curr Probl Diagn Radiol"},{"issue":"4","key":"10.1016\/j.eprac.2025.05.743_bib44","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1148\/radiographics.21.4.g01jl21995","article-title":"State-of-the-art adrenal imaging","volume":"21","author":"Mayo-Smith","year":"2001","journal-title":"Radiographics"},{"issue":"3","key":"10.1016\/j.eprac.2025.05.743_bib45","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1148\/radiology.217.3.r00dc29798","article-title":"Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT","volume":"217","author":"Pe\u00f1a","year":"2000","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.eprac.2025.05.743_bib46","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00261-003-0015-0","article-title":"Differentiation of adrenal adenomas (lipid rich and lipid poor) from nonadenomas by use of washout characteristics on delayed enhanced CT","volume":"28","author":"Kebapci","year":"2003","journal-title":"Abdom Imaging"},{"issue":"5","key":"10.1016\/j.eprac.2025.05.743_bib47","doi-asserted-by":"crossref","first-page":"804","DOI":"10.2214\/AJR.22.27901","article-title":"Incidental adrenal nodules in patients without known malignancy: prevalence of malignancy and utility of washout CT for characterization-A multiinstitutional study","volume":"219","author":"Corwin","year":"2022","journal-title":"Am J Roentgenol"},{"issue":"6","key":"10.1016\/j.eprac.2025.05.743_bib48","doi-asserted-by":"crossref","first-page":"694","DOI":"10.5152\/dir.2021.20508","article-title":"Are the washout values currently accepted for lesion characterization in dedicated adrenal CT adequate for diagnosis?","volume":"27","author":"G\u00fcndo\u011fdu","year":"2021","journal-title":"Diagn Interv Radiol"},{"issue":"2","key":"10.1016\/j.eprac.2025.05.743_bib49","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1530\/EJE-21-0650","article-title":"Adrenal wash-out CT: moderate diagnostic value in distinguishing benign from malignant adrenal masses","volume":"186","author":"Schloetelburg","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.eprac.2025.05.743_bib50","doi-asserted-by":"crossref","DOI":"10.2214\/AJR.23.30769","article-title":"Performance of CT with adrenal-washout protocol in heterogeneous adrenal nodules: a multiinstitutional study","author":"Corwin","year":"2024","journal-title":"Am J Roentgenol"},{"issue":"2","key":"10.1016\/j.eprac.2025.05.743_bib51","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1148\/radiol.12120110","article-title":"Evaluation of adrenal metastases from renal cell carcinoma and hepatocellular carcinoma: use of delayed contrast-enhanced CT","volume":"266","author":"Choi","year":"2013","journal-title":"Radiology"},{"issue":"Suppl 1","key":"10.1016\/j.eprac.2025.05.743_bib52","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1148\/rg.24si045506","article-title":"Pheochromocytoma: an imaging chameleon","volume":"24","author":"Blake","year":"2004","journal-title":"Radiographics"},{"issue":"3","key":"10.1016\/j.eprac.2025.05.743_bib53","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s00330-017-5076-5","article-title":"Pheochromocytoma as a frequent false-positive in adrenal washout CT: a systematic review and meta-analysis","volume":"28","author":"Woo","year":"2018","journal-title":"Eur Radiol"},{"issue":"3","key":"10.1016\/j.eprac.2025.05.743_bib54","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2214\/AJR.14.12941","article-title":"Characterization of adrenal lesions at chemical-shift MRI: a direct intraindividual comparison of in- and opposed-phase imaging at 1.5 T and 3 T","volume":"204","author":"Ream","year":"2015","journal-title":"Am J Roentgenol"},{"issue":"4","key":"10.1016\/j.eprac.2025.05.743_bib55","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1002\/jmri.26542","article-title":"Renal and adrenal masses containing fat at MRI: proposed nomenclature by the society of abdominal radiology disease-focused panel on renal cell carcinoma","volume":"49","author":"Schieda","year":"2019","journal-title":"J Magn Reson Imaging"},{"issue":"2","key":"10.1016\/j.eprac.2025.05.743_bib56","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1007\/s00330-018-5626-5","article-title":"Chemical shift imaging for evaluation of adrenal masses: a systematic review and meta-analysis","volume":"29","author":"Platzek","year":"2019","journal-title":"Eur Radiol"},{"issue":"1","key":"10.1016\/j.eprac.2025.05.743_bib57","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2214\/ajr.165.1.7785642","article-title":"Characterization of adrenal masses (< 5 cm) by use of chemical shift MR imaging: observer performance versus quantitative measures","volume":"165","author":"Mayo-Smith","year":"1995","journal-title":"Am J Roentgenol"},{"issue":"6","key":"10.1016\/j.eprac.2025.05.743_bib58","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.2214\/AJR.16.17758","article-title":"Update on CT and MRI of adrenal nodules","volume":"208","author":"Schieda","year":"2017","journal-title":"Am J Roentgenol"},{"issue":"3","key":"10.1016\/j.eprac.2025.05.743_bib59","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1148\/radiol.2313030676","article-title":"Chemical shift MR imaging of hyperattenuating (>10 HU) adrenal masses: does it still have a role?","volume":"231","author":"Haider","year":"2004","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.eprac.2025.05.743_bib60","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s00261-014-0208-8","article-title":"Low yield of chemical shift MRI for characterization of adrenal lesions with high attenuation density on unenhanced CT","volume":"40","author":"Sebro","year":"2015","journal-title":"Abdom Imaging"},{"issue":"5","key":"10.1016\/j.eprac.2025.05.743_bib61","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.2214\/AJR.13.11389","article-title":"Characterization of lipid-poor adrenal adenoma: chemical-shift MRI and washout CT","volume":"202","author":"Seo","year":"2014","journal-title":"Am J Roentgenol"},{"issue":"2","key":"10.1016\/j.eprac.2025.05.743_bib62","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2214\/ajr.166.2.8553954","article-title":"Adrenal myelolipoma","volume":"166","author":"Cyran","year":"1996","journal-title":"Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.eprac.2025.05.743_bib63","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2214\/AJR.13.11731","article-title":"Combined chemical shift imaging with early dynamic serial gadolinium-enhanced MRI in the characterization of adrenal lesions","volume":"203","author":"Rodacki","year":"2014","journal-title":"Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.eprac.2025.05.743_bib64","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ejrad.2007.03.012","article-title":"Dynamic contrast enhanced MRI in the differential diagnosis of adrenal adenomas and malignant adrenal masses","volume":"65","author":"Inan","year":"2008","journal-title":"Eur J Radiol"},{"issue":"11","key":"10.1016\/j.eprac.2025.05.743_bib65","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/j.ejrad.2015.06.032","article-title":"Differentiation of lipid-poor adrenal adenomas from non-adenomas with magnetic resonance imaging: utility of dynamic, contrast enhancement and single-shot T2-weighted sequences","volume":"84","author":"Becker-Weidman","year":"2015","journal-title":"Eur J Radiol"},{"issue":"14","key":"10.1016\/j.eprac.2025.05.743_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15143736","article-title":"An integrated CT and MRI imaging model to differentiate between adrenal adenomas and pheochromocytomas","volume":"15","author":"Araujo-Castro","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.eprac.2025.05.743_bib67","doi-asserted-by":"crossref","first-page":"W179","DOI":"10.2214\/AJR.09.2891","article-title":"Utility of diffusion-weighted MRI in characterization of adrenal lesions","volume":"194","author":"Miller","year":"2010","journal-title":"Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.eprac.2025.05.743_bib68","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/jmri.21616","article-title":"Diagnostic utility of diffusion-weighted MR imaging and apparent diffusion coefficient value for the diagnosis of adrenal tumors","volume":"29","author":"Tsushima","year":"2009","journal-title":"J Magn Reson Imaging"},{"issue":"7","key":"10.1016\/j.eprac.2025.05.743_bib69","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41574-021-00492-3","article-title":"International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers","volume":"17","author":"Amar","year":"2021","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"10.1016\/j.eprac.2025.05.743_bib70","first-page":"32","article-title":"18F-FDG PET\/CT in the evaluation of adrenal masses","volume":"47","author":"Metser","year":"2006","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.eprac.2025.05.743_bib71","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40644-016-0084-2","article-title":"(68)Ga-DOTATATE and (18)F-FDG PET\/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity","volume":"16","author":"Chang","year":"2016","journal-title":"Cancer Imaging"},{"issue":"11","key":"10.1016\/j.eprac.2025.05.743_bib72","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1007\/s00259-008-0849-3","article-title":"Does 18F-FDG PET\/CT add diagnostic accuracy in incidentally identified non-secreting adrenal tumours?","volume":"35","author":"Tessonnier","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.eprac.2025.05.743_bib73","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1148\/radiol.11100569","article-title":"Characterization of adrenal masses by using FDG PET: a systematic review and meta-analysis of diagnostic test performance","volume":"259","author":"Boland","year":"2011","journal-title":"Radiology"},{"issue":"12","key":"10.1016\/j.eprac.2025.05.743_bib74","first-page":"2058","article-title":"18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer","volume":"45","author":"Kumar","year":"2004","journal-title":"J Nucl Med"},{"issue":"4","key":"10.1016\/j.eprac.2025.05.743_bib75","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1102\/1470-7330.2013.0053","article-title":"Adrenal collision tumors and their mimics: multimodality imaging findings","volume":"13","author":"Katabathina","year":"2013","journal-title":"Cancer Imaging"},{"issue":"5","key":"10.1016\/j.eprac.2025.05.743_bib76","doi-asserted-by":"crossref","first-page":"450","DOI":"10.4158\/EP.15.5.450","article-title":"American association of clinical endocrinologists and American association of endocrine surgeons medical guidelines for the management of adrenal incidentalomas: executive summary of recommendations","volume":"15","author":"Zeiger","year":"2009","journal-title":"Endocr Pract"},{"issue":"4","key":"10.1016\/j.eprac.2025.05.743_bib77","doi-asserted-by":"crossref","first-page":"241","DOI":"10.5489\/cuaj.11135","article-title":"Guidelines for the management of the incidentally discovered adrenal mass","volume":"5","author":"Kapoor","year":"2011","journal-title":"Can Urol Assoc J"},{"issue":"2","key":"10.1016\/j.eprac.2025.05.743_bib78","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3803\/EnM.2017.32.2.200","article-title":"Clinical guidelines for the management of adrenal incidentaloma","volume":"32","author":"Lee","year":"2017","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"Suppl 1","key":"10.1016\/j.eprac.2025.05.743_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP.15.S1.1","article-title":"The American association of clinical endocrinologists and American association of endocrine surgeons medical guidelines for the management of adrenal incidentalomas","volume":"15","author":"Zeiger","year":"2009","journal-title":"Endocr Pract"},{"issue":"2","key":"10.1016\/j.eprac.2025.05.743_bib80","doi-asserted-by":"crossref","first-page":"178","DOI":"10.4158\/DSCR-2018-0565","article-title":"The evaluation of incidentally discovered adrenal masses","volume":"25","author":"Vaidya","year":"2019","journal-title":"Endocr Pract"},{"issue":"3","key":"10.1016\/j.eprac.2025.05.743_bib81","doi-asserted-by":"crossref","first-page":"325","DOI":"10.7326\/M21-1737","article-title":"Cardiometabolic disease burden and steroid excretion in benign adrenal tumors : a cross-sectional multicenter study","volume":"175","author":"Prete","year":"2022","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.eprac.2025.05.743_bib82","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/ejendo\/lvad113","article-title":"High prevalence of frailty in patients with adrenal adenomas and adrenocortical hormone excess: a cross-sectional multi-centre study with prospective enrolment","volume":"189","author":"Dogra","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.eprac.2025.05.743_bib83","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1093\/ejendo\/lvad134","article-title":"Comorbidities in mild autonomous cortisol secretion and the effect of treatment: systematic review and meta-analysis","volume":"189","author":"Pelsma","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"10.1016\/j.eprac.2025.05.743_bib84","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1210\/jc.2018-01865","article-title":"Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice guideline","volume":"103","author":"Speiser","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.eprac.2025.05.743_bib85","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14030594","article-title":"New insights on the genetics of pheochromocytoma and paraganglioma and its clinical implications","volume":"14","author":"Jhawar","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.eprac.2025.05.743_bib86","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jacr.2017.05.001","article-title":"Management of incidental adrenal masses: a white paper of the ACR incidental findings committee","volume":"14","author":"Mayo-Smith","year":"2017","journal-title":"J Am Coll Radiol"},{"issue":"3","key":"10.1016\/j.eprac.2025.05.743_bib87","doi-asserted-by":"crossref","first-page":"632","DOI":"10.2214\/AJR.19.21342","article-title":"Differences in growth rate on CT of adrenal adenomas and malignant adrenal nodules","volume":"213","author":"Corwin","year":"2019","journal-title":"Am J Roentgenol"},{"issue":"4","key":"10.1016\/j.eprac.2025.05.743_bib88","doi-asserted-by":"crossref","first-page":"577","DOI":"10.4158\/EP09351.OR","article-title":"Change in adrenal mass size as a predictor of a malignant tumor","volume":"16","author":"Pantalone","year":"2010","journal-title":"Endocr Pract"},{"issue":"3","key":"10.1016\/j.eprac.2025.05.743_bib89","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.juro.2011.04.072","article-title":"Effects of increased cross-sectional imaging on the diagnosis and prognosis of adrenocortical carcinoma: analysis of the National Cancer Database","volume":"186","author":"Kutikov","year":"2011","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.eprac.2025.05.743_bib90","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3109\/0284186X.2011.608084","article-title":"Adrenal lesions in patients with extra-adrenal malignancy - benign or malignant?","volume":"51","author":"Hammarstedt","year":"2012","journal-title":"Acta Oncol"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25008948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25008948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T07:20:02Z","timestamp":1778224802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X25008948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":91,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1530891X25008948"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2025.05.743","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imaging of Adrenal Masses","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2025.05.743","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 AACE. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}